William E. Delaney
Chief Scientific OfficerDr. William E. Delaney IV, also known as Bill, Ph.D., serves as Chief Scientific Officer at Assembly Biosciences, Inc. since 2021 and served as its Chief Scientific Officer of Virology from May 27, 2020 until 2021. Dr. Delaney joined Assembly from Gilead where he served as Executive Director, Biology. During his 20-year career at the company, he headed the Viral Hepatitis & Herpes Discovery Biology Groups and served as the Research Therapeutic Area Head for HBV. He began his career as a Research Scientist, Clinical Virology at Gilead and later transitioned into Drug Discovery where he held positions of increasing responsibility. He earned a BS in Biotechnology from the University of Delaware and a Ph.D. in Cell and Molecular Biology from the Penn State College of Medicine. In addition, he was a Postdoctoral Fellow at the Victorian Infectious Diseases Reference Laboratory (VIDRL), Department of Research & Molecular Development from 1999 until 2000.
Positions
- Company NameAssembly Biosciences, Inc.Stock CodeASMBPositionChief Scientific OfficerColleagues
- JAJason A. OkazakiCEO, President & Director
- AEAnthony E. AltigIndependent Chairman
- AGAnuj GaggarChief Medical Officer
- JMJeanette M. BjorkquistPrincipal Financial Officer, Executive Director of Accounting & Treasury
- SRShannon RyanSenior Vice President of Investor Relations, Corporate Affairs & Alliance Management
- SMSusan M. MahonyIndependent Director
- GRGina R. ConsylmanIndependent Director
- LRLisa R. Johnson-PrattIndependent Director
